The vaccine has been evaluated in more than 1,000 healthy adult volunteers aged between 18 and 55 years in a randomised controlled trials.
Oxford and AstraZeneca are collaborating with clinical partners around the world as part of a global clinical programme to get a vaccine.
The vaccine provoked a T cell response within 14 days of vaccination , and an antibody response within 28 days .During the study, participants who received the vaccine had detectable neutralising antibodies, which have been suggested by researchers as important for protection, and these responses were strongest after a booster dose, with 100 per cent of participants’ blood having neutralising activity against the coronavirus.
A UK Phase I/II trial began in April testing the Oxford coronavirus vaccine ChAdOx1 nCoV-19. The team started working to develop a vaccine against the global threat in January 2020 and have been working with unprecedented urgency in a race against the coronavirus. The University of Oxford is working with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the vaccine, with plans for clinical development and production of the Oxford vaccine progressing globally.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: Oxford vaccine safe, triggers immune responseWe are a quality, national, newspaper with credible and dependable information.
Read more »
Weekly Review: After two weeks of reduction, Nigeria's new COVID-19 cases increase...while a total of 3,823 new infections were recorded in the previous week, Nigeria recorded 4,107 new COVID-19 cases in the past week...
Read more »
Osun records four new COVID-19 cases
Read more »
Osun govt records four new COVID-19 cases, discharges 11 patients - Daily Post NigeriaThe Osun State Government, on Sunday, announced the discovery of four new COVID-19 cases in the State. The State also discharged 11 patients from its
Read more »